Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease
Basel, January 16, 2026 – Novartis today announced that the US Food and…
U.S. FDA Approves Agios AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and…
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
The secondary analysis of the PACE trial highlights the value of counting…
Global study targets dengue as disease threatens nearly half the world’s population
LISMORE, Australia, Dec. 18, 2025 /PRNewswire/ -- Thousands of dengue forecasting models…
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
Manipal Hospitals Enhances Movement and Confidence Through Awareness on Movement Disorders
BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear…
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results…
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease
December 05, 2025 08:00 ET | Source: Amneal Pharmaceuticals LLC Interim data…
A Mother’s Gift of Life: Successful Living-Donor Kidney Transplant Restores Hope for 32 Years old Young CKD Patient from Bangladesh
HYDERABAD, India, Nov. 24, 2025 /PRNewswire/ -- In an inspiring story of…